INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 46h ago
HOUSE PTR6h ago
SEC 13F6h ago
ROBINHOOD CHAIN6h ago
SEC FORM 4/Grant or awardVerified data

Burton Paul Frederick reported CDIO

Director · Cardio Diagnostics Holdings, Inc. · Cardio Diagnostics Holdings, Inc. — Stock Options (Right to Buy)

Side
A
Value
$6,243
Shares
3,286
Price
$1.9
Executed
Sep 30, 2026
Disclosed
Oct 2, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Sep 30 executedOct 2, 2026 disclosed

CDIO · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
17/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+9 / 25

$6K reported value · 24.7% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · CDIO

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    17
    FK
    Fung Peter KDirector
    CDIOCardio Diagnostics Holdings, Inc.
    Grant or award
    		A$6,243
    3,286 sh
    		Sep 30, 2026Oct 2, 2026
    traded Sep 30, 2026
    		+2dSEC FORM 4

    Evidence

    17
    BJ
    Betts Wendy JDirector
    CDIOCardio Diagnostics Holdings, Inc.
    Grant or award
    		A$6,243
    3,286 sh
    		Sep 30, 2026Oct 2, 2026
    traded Sep 30, 2026
    		+2dSEC FORM 4

    Evidence

    17
    BJ
    Betts Wendy JDirector
    CDIOCardio Diagnostics Holdings, Inc.
    Grant or award
    		A$6,250
    2,854 sh
    		Jun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dSEC FORM 4

    Evidence

    17
    FK
    Fung Peter KDirector
    CDIOCardio Diagnostics Holdings, Inc.
    Grant or award
    		A$6,250
    2,854 sh
    		Jun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dSEC FORM 4

    Evidence

    21
    BJ
    Betts Wendy JDirector
    CDIOCardio Diagnostics Holdings, Inc.
    Grant or award
    		A$6,250
    3,205 sh
    		Mar 31, 2026Apr 2, 2026
    traded Mar 31, 2026
    		+2dSEC FORM 4

    Evidence

    21
    FK
    Fung Peter KDirector
    CDIOCardio Diagnostics Holdings, Inc.
    Grant or award
    		A$6,250
    3,205 sh
    		Mar 31, 2026Apr 2, 2026
    traded Mar 31, 2026
    		+2dSEC FORM 4

    Evidence

    23
    BF
    Burton Paul FrederickDirector
    CDIOCardio Diagnostics Holdings, Inc.
    Grant or award
    		A$6,249
    2,306 sh
    		Dec 31, 2025Jan 6, 2026
    traded Dec 31, 2025
    		+6dSEC FORM 4

    Evidence

    27
    BJ
    Betts Wendy JDirector
    CDIOCardio Diagnostics Holdings, Inc.
    Grant or award
    		A$6,249
    2,306 sh
    		Dec 31, 2025Jan 6, 2026
    traded Dec 31, 2025
    		+6dSEC FORM 4

    Evidence

    27
    FK
    Fung Peter KDirector
    CDIOCardio Diagnostics Holdings, Inc.
    Grant or award
    		A$6,249
    2,306 sh
    		Dec 31, 2025Jan 6, 2026
    traded Dec 31, 2025
    		+6dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002006956-26-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Sep 30, 2026
    Published
    Oct 2, 2026
    Ingested by INSIDER
    Nov 5, 02:13 UTC
    Last re-read
    Nov 5, 02:13 UTC

    Extracted facts

    Filer
    Burton Paul Frederick
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Cardio Diagnostics Holdings, Inc. — Stock Options (Right to Buy)
    Ticker
    CDIO
    Shares
    3,286
    Price per share
    $1.9
    Value
    $6,243
    Execution date (reported)
    Sep 30, 2026
    Owned after transaction
    16.6K shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 3,286
    • Price: $1.9

    = $6,243

    What this establishes

    Burton Paul Frederick filed this Form 4 reporting a grant or award of CDIO on Sep 30, 2026. It became public on Oct 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Burton Paul Frederickcik:0002006956
    Issuer
    Cardio Diagnostics Holdings, Inc.cik:0001870144

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.